AIMI - AIM ImmunoTech Inc.
10.15
0.650 6.404%
Share volume: 97,105
Last Updated: 06-17-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.50
0.65
0.07%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2025 | 08-14-2025 | 11-17-2025 | |
| Total revenue | 16.000 K | 25.000 K | 26.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 16.000 K | 25.000 K | 26.000 K | |
| 56.25% | 4.00% | |||
| Operating expenses | 3.625 M | 2.661 M | 2.405 M | |
| Selling general and admin | 2.545 M | 1.487 M | 1.798 M | |
| Research and development | 1.080 M | 1.174 M | 607.000 K | |
| Total expenses | 3.635 M | 2.671 M | 2.473 M | |
| -26.52% | -7.41% | |||
| Operating income | -3.619 M | -2.646 M | -2.447 M | |
| Ebit | -3.619 M | -2.646 M | -6.187 M | |
| Pretax income | -3.716 M | -2.804 M | -6.336 M | |
| -24.54% | 125.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -3.705 M | -2.794 M | -3.284 M | |
| 24.59% | -17.54% |